Trellus Management Company’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-127,000
| Closed | -$281K | – | 78 |
|
|
2023
Q2 | $281K | Hold |
127,000
| – | – | 0.35% | 51 |
|
|
2023
Q1 | $323K | Sell |
127,000
-168,000
| -57% | -$332K | 0.38% | 38 |
|
|
2022
Q4 | $552K | Hold |
295,000
| – | – | 0.7% | 28 |
|
|
2022
Q3 | $758K | Hold |
295,000
| – | – | 0.92% | 17 |
|
|
2022
Q2 | $569K | Hold |
295,000
| – | – | 0.69% | 26 |
|
|
2022
Q1 | $876K | Hold |
295,000
| – | – | 0.51% | 24 |
|
|
2021
Q4 | $1.32M | Hold |
295,000
| – | – | 0.88% | 22 |
|
|
2021
Q3 | $1.43M | Buy |
295,000
+10,600
| +4% | +$58.4K | 1.04% | 25 |
|
|
2021
Q2 | $1.94M | Sell |
284,400
-55,600
| -16% | -$450K | 1.34% | 19 |
|
|
2021
Q1 | $2.4M | Hold |
340,000
| – | – | 1.24% | 16 |
|
|
2020
Q4 | $2.13M | Buy |
340,000
+40,000
| +13% | +$235K | 1.76% | 13 |
|
|
2020
Q3 | $1.62M | Hold |
300,000
| – | – | 1.66% | 15 |
|
|
2020
Q2 | $1.57M | Buy |
300,000
+72,300
| +32% | +$321K | 1.7% | 15 |
|
|
2020
Q1 | $717K | Buy |
227,700
+80,645
| +55% | +$297K | 1.29% | 27 |
|
|
2019
Q4 | $593K | Sell |
147,055
-37,945
| -21% | -$132K | 0.99% | 30 |
|
|
2019
Q3 | $799K | Buy |
185,000
+20,000
| +12% | +$80K | 0.8% | 26 |
|
|
2019
Q2 | $658K | Buy |
165,000
+65,000
| +65% | +$309K | 0.89% | 36 |
|
|
2019
Q1 | $536K | Buy |
100,000
+28,800
| +40% | +$186K | 1.02% | 31 |
|
|
2018
Q4 | $365K | Sell |
71,200
-28,800
| -29% | -$219K | 0.82% | 34 |
|
|
2018
Q3 | $970K | Hold |
100,000
| – | – | 1.4% | 21 |
|
|
2018
Q2 | $1.02M | Buy |
100,000
+10,300
| +11% | +$117K | 1.5% | 17 |
|
|
2018
Q1 | $1.17M | Buy |
89,700
+49,700
| +124% | +$740K | 2.12% | 16 |
|
|
2017
Q4 | $716K | Buy |
40,000
+20,000
| +100% | +$417K | 0.98% | 26 |
|
|
2017
Q3 | $502K | Buy |
+20,000
| New | +$466K | 0.69% | 40 |
|
Trellus Management Company's PRTK Position: Q3 2023 in Review
Trellus Management Company sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 127,000 shares — an estimated $281K sold.
Trellus Management Company first reported a position in PRTK in Q3 2017 and held it in 24 quarters. The position peaked at $2.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- Trellus Management Company reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Trellus Management Company sold 127,000 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $281K.
- Trellus Management Company first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2017 and held it in 24 quarters.
- Trellus Management Company's Paratek Pharmaceuticals, Inc. position peaked at $2.4M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on Trellus Management Company's 13F filing for Q3 2023, filed 24 Oct 2023.